老年子宫内膜癌患者的胃肠道结局
在SEER-Medicare关联数据中,纳入2004-2017年确诊的66岁及以上子宫内膜癌患者44386例及无癌症史匹配女性221219例,比较索引日期后胃肠道诊断风险。子宫内膜癌患者便秘、腹痛、大便失禁、肠梗阻及肠麻痹风险均升高,敏感性分析限于索引日期后1年以上及5年以上仍显示关联。
要点
- 老年子宫内膜癌患者便秘风险升高(HR=2.27;95%CI:2.22-2.32)。
- 腹痛风险升高(HR=2.94;95%CI:2.89-2.99),大便失禁风险升高(HR=1.96;95%CI:1.83-2.10)。
- 肠梗阻(HR=5.72;95%CI:5.47-5.98)与肠麻痹(HR=7.22;95%CI:6.89-7.57)风险亦升高。
核心结论
- 老年子宫内膜癌患者存在过量的胃肠道诊断风险,且可能在癌症诊断后长期持续。
研究设计与样本
- 在SEER-Medicare关联数据中识别2004-2017年确诊的66岁及以上子宫内膜癌患者44386例及无已知癌症史匹配女性221219例。
- 以匹配集中子宫内膜癌诊断日期定义索引日期,采用ICD-9和ICD-10诊断代码在Medicare索赔中定义胃肠道结局。
- 使用多变量Cox比例风险回归模型估计新发胃肠道诊断的风险比(HR)。
主要发现
- 与无癌症女性相比,子宫内膜癌女性索引日期后胃肠道症状风险升高:便秘HR=2.27(95%CI:2.22-2.32),腹痛HR=2.94(95%CI:2.89-2.99),大便失禁HR=1.96(95%CI:1.83-2.10)。
- 子宫内膜癌女性其他胃肠道诊断风险亦较高,例如肠梗阻HR=5.72(95%CI:5.47-5.98),肠麻痹HR=7.22(95%CI:6.89-7.57)。
- 敏感性分析限于索引日期后1年以上及5年以上,这些关联仍然明显。
关键数值与推荐
- 胃肠道结局包括便秘、腹痛、肠易激综合征、大便失禁、肠梗阻、肠麻痹、放射性肠炎或直肠炎、结肠狭窄及肠道血管功能不全。
临床怎么用
- 作者认为,对这些疾病的监测可能是肿瘤生存者照护的关键部分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Treatment for endometrial cancer may contribute to bowel dysfunction and other gastrointestinal outcomes. We investigated the risk of several gastrointestinal diagnoses among older women with endometrial cancer and matched women without a history of cancer. METHODS: Women aged 66 years and older diagnosed with endometrial cancer during 2004-2017 (N = 44,386) and matched women without a known cancer history (N = 221,219) were identified in the SEER-Medicare linked data. An index date was defined as the endometrial cancer diagnosis date in that matched set. ICD-9 and -10 diagnosis codes were used to define gastrointestinal outcomes, including constipation, abdominal pain, IBS, fecal incontinence, bowel obstruction, ileus, radiation enteritis or proctitis, colonic stricture, and vascular insufficiency of the bowel in the Medicare claims. Hazard ratios (HRs) for incident gastrointestinal diagnoses were estimated using multivariable Cox proportional hazards regression models. RESULTS: Compared to women without cancer, women with endometrial cancer had an increased risk of gastrointestinal symptoms after the index date, including constipation (HR = 2.27; 95% CI: 2.22-2.32), abdominal pain (HR = 2.94; 95% CI: 2.89-2.99), and fecal incontinence (HR = 1.96; 95% CI: 1.83-2.10). The risk of other gastrointestinal diagnoses was also higher among women with endometrial cancer (e.g., bowel obstruction: HR = 5.72; 95% CI: 5.47-5.98; ileus: HR = 7.22; 95% CI: 6.89-7.57). These associations were also apparent in sensitivity analyses limited to 1+ and 5+ years after the index date. CONCLUSIONS: Older women with endometrial cancer experience an excess risk of gastrointestinal diagnoses that may persist long after cancer diagnosis. Surveillance for these conditions may be a critical part of survivorship care.
引用
- Anderson C, Peery AF, Bae-Jump VL, et al. Gastrointestinal outcomes among older women with endometrial cancer. Gynecol Oncol. 2023. PMID: 37354788. doi:10.1016/j.ygyno.2023.06.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。